Mouse cardiac Pde1C is a direct transcriptional target of pparα

Varsha Shete, Ning Liu, Yuzhi Jia, Navin Viswakarma, Janardan K. Reddy, Bayar Thimmapaya*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Phosphodiesterase 1C (PDE1C) is expressed in mammalian heart and regulates cardiac functions by controlling levels of second messenger cyclic AMP and cyclic GMP (cAMP and cGMP, respectively). However, molecular mechanisms of cardiac Pde1c regulation are currently unknown. In this study, we demonstrate that treatment of wild type mice and H9c2 myoblasts with Wy-14,643, a potent ligand of nuclear receptor peroxisome-proliferator activated receptor alpha (PPARα), leads to elevated cardiac Pde1C mRNA and cardiac PDE1C protein, which correlate with reduced levels of cAMP. Furthermore, using mice lacking either Pparα or cardiomyocyte-specific Med1, the major subunit of Mediator complex, we show that Wy-14,643-mediated Pde1C induction fails to occur in the absence of Pparα and Med1 in the heart. Finally, using chromatin immunoprecipitation assays we demonstrate that PPARα binds to the upstream Pde1C promoter sequence on two sites, one of which is a palindrome sequence (agcTAGGttatcttaacctagc) that shows a robust binding. Based on these observations, we conclude that cardiac Pde1C is a direct transcriptional target of PPARα and that Med1 may be required for the PPARα mediated transcriptional activation of cardiac Pde1C.

Original languageEnglish (US)
Article number3704
JournalInternational journal of molecular sciences
Volume19
Issue number12
DOIs
StatePublished - Dec 2018

Fingerprint

PPAR alpha
mice
Phosphoric Diester Hydrolases
Mediator Complex
Inverted Repeat Sequences
cyclic AMP
Myoblasts
Chromatin Immunoprecipitation
Cyclic GMP
Second Messenger Systems
Cytoplasmic and Nuclear Receptors
chromatin
Cardiac Myocytes
Cyclic AMP
Transcriptional Activation
Chromatin
Assays
Chemical activation
Ligands
upstream

Keywords

  • Med1
  • PPARα
  • Phosphodiesterase 1C
  • cAMP

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

@article{b86c2652604e40adb1465142ad6ad089,
title = "Mouse cardiac Pde1C is a direct transcriptional target of pparα",
abstract = "Phosphodiesterase 1C (PDE1C) is expressed in mammalian heart and regulates cardiac functions by controlling levels of second messenger cyclic AMP and cyclic GMP (cAMP and cGMP, respectively). However, molecular mechanisms of cardiac Pde1c regulation are currently unknown. In this study, we demonstrate that treatment of wild type mice and H9c2 myoblasts with Wy-14,643, a potent ligand of nuclear receptor peroxisome-proliferator activated receptor alpha (PPARα), leads to elevated cardiac Pde1C mRNA and cardiac PDE1C protein, which correlate with reduced levels of cAMP. Furthermore, using mice lacking either Pparα or cardiomyocyte-specific Med1, the major subunit of Mediator complex, we show that Wy-14,643-mediated Pde1C induction fails to occur in the absence of Pparα and Med1 in the heart. Finally, using chromatin immunoprecipitation assays we demonstrate that PPARα binds to the upstream Pde1C promoter sequence on two sites, one of which is a palindrome sequence (agcTAGGttatcttaacctagc) that shows a robust binding. Based on these observations, we conclude that cardiac Pde1C is a direct transcriptional target of PPARα and that Med1 may be required for the PPARα mediated transcriptional activation of cardiac Pde1C.",
keywords = "Med1, PPARα, Phosphodiesterase 1C, cAMP",
author = "Varsha Shete and Ning Liu and Yuzhi Jia and Navin Viswakarma and Reddy, {Janardan K.} and Bayar Thimmapaya",
year = "2018",
month = "12",
doi = "10.3390/ijms19123704",
language = "English (US)",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

Mouse cardiac Pde1C is a direct transcriptional target of pparα. / Shete, Varsha; Liu, Ning; Jia, Yuzhi; Viswakarma, Navin; Reddy, Janardan K.; Thimmapaya, Bayar.

In: International journal of molecular sciences, Vol. 19, No. 12, 3704, 12.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mouse cardiac Pde1C is a direct transcriptional target of pparα

AU - Shete, Varsha

AU - Liu, Ning

AU - Jia, Yuzhi

AU - Viswakarma, Navin

AU - Reddy, Janardan K.

AU - Thimmapaya, Bayar

PY - 2018/12

Y1 - 2018/12

N2 - Phosphodiesterase 1C (PDE1C) is expressed in mammalian heart and regulates cardiac functions by controlling levels of second messenger cyclic AMP and cyclic GMP (cAMP and cGMP, respectively). However, molecular mechanisms of cardiac Pde1c regulation are currently unknown. In this study, we demonstrate that treatment of wild type mice and H9c2 myoblasts with Wy-14,643, a potent ligand of nuclear receptor peroxisome-proliferator activated receptor alpha (PPARα), leads to elevated cardiac Pde1C mRNA and cardiac PDE1C protein, which correlate with reduced levels of cAMP. Furthermore, using mice lacking either Pparα or cardiomyocyte-specific Med1, the major subunit of Mediator complex, we show that Wy-14,643-mediated Pde1C induction fails to occur in the absence of Pparα and Med1 in the heart. Finally, using chromatin immunoprecipitation assays we demonstrate that PPARα binds to the upstream Pde1C promoter sequence on two sites, one of which is a palindrome sequence (agcTAGGttatcttaacctagc) that shows a robust binding. Based on these observations, we conclude that cardiac Pde1C is a direct transcriptional target of PPARα and that Med1 may be required for the PPARα mediated transcriptional activation of cardiac Pde1C.

AB - Phosphodiesterase 1C (PDE1C) is expressed in mammalian heart and regulates cardiac functions by controlling levels of second messenger cyclic AMP and cyclic GMP (cAMP and cGMP, respectively). However, molecular mechanisms of cardiac Pde1c regulation are currently unknown. In this study, we demonstrate that treatment of wild type mice and H9c2 myoblasts with Wy-14,643, a potent ligand of nuclear receptor peroxisome-proliferator activated receptor alpha (PPARα), leads to elevated cardiac Pde1C mRNA and cardiac PDE1C protein, which correlate with reduced levels of cAMP. Furthermore, using mice lacking either Pparα or cardiomyocyte-specific Med1, the major subunit of Mediator complex, we show that Wy-14,643-mediated Pde1C induction fails to occur in the absence of Pparα and Med1 in the heart. Finally, using chromatin immunoprecipitation assays we demonstrate that PPARα binds to the upstream Pde1C promoter sequence on two sites, one of which is a palindrome sequence (agcTAGGttatcttaacctagc) that shows a robust binding. Based on these observations, we conclude that cardiac Pde1C is a direct transcriptional target of PPARα and that Med1 may be required for the PPARα mediated transcriptional activation of cardiac Pde1C.

KW - Med1

KW - PPARα

KW - Phosphodiesterase 1C

KW - cAMP

UR - http://www.scopus.com/inward/record.url?scp=85057071401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057071401&partnerID=8YFLogxK

U2 - 10.3390/ijms19123704

DO - 10.3390/ijms19123704

M3 - Article

C2 - 30469494

AN - SCOPUS:85057071401

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 3704

ER -